Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I/II Study of Hypofractionated Proton Therapy for Stage II-III Non-Small Cell Lung Cancer

NCT01770418 is registered in ClinicalTrials.gov with Proton Collaborative Group as lead sponsor.

NCT NCT01770418
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01770418 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I/II Study of Hypofractionated Proton Therapy for Stage II-III Non-Small Cell Lung Cancer
Lead sponsor
Proton Collaborative Group
Phase
Phase 1/2
Overall status
Active, not recruiting
Start date
March 31, 2013
Completion date
Not reported
Enrollment
32 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

lung neoplasms